Daniel Barber
Overview
Daniel Barber received an average of $2M in total compensation, including $447K in salary, at Aquestive Therapeutics from 2018 to 2023.
2023Aquestive TherapeuticsChief Executive Officer
2022Aquestive TherapeuticsChief Executive Officer
2021Aquestive TherapeuticsChief Operating Officer
2020Aquestive TherapeuticsChief Operating Officer
2019Aquestive TherapeuticsChief Operating Officer
2018Aquestive TherapeuticsChief Operating Officer
Source: SEC filings on April 26, 2024, April 29, 2022, May 5, 2021, and April 29, 2020.
Related executives
We found four more executives who work or worked at Aquestive Therapeutics.
News
Aquestive Therapeutics CEO Daniel Barber's 2023 pay jumps 88% to $2.5M
April 26, 2024
Aquestive Therapeutics CEO Keith Kendall's 2021 pay jumps 59% to $2M
April 29, 2022
Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M
May 5, 2021
Aquestive Therapeutics CEO Keith Kendall's 2019 pay falls 67% to $2.6M
April 29, 2020